English English Spanish Spanish
Latest Physician News2019-02-15T12:10:02+00:00

Latest in Sleep Medicine News

PAP may reduce mortality in patients with obesity and severe OSA

The prescription of positive airway pressure is associated with reduced all-cause mortality, according to the results of a cohort study published in JAMA Otolaryngology–Head & Neck Surgery.

The association becomes evident several years after positive airway pressure (PAP) initiation, according to the researchers. Obstructive sleep apnea (OSA) is among the top 10 modifiable cardiovascular risk factors, and is associated with increased risks of coronary artery disease, stroke, and death. PAP is the most effective treatment for OSA, but this treatment’s effect on all-cause and cardiovascular mortality is uncertain. Randomized trials have yielded inconclusive answers to this question, and evidence from observational studies has been weak.

To investigate the association between PAP prescription and mortality in patients with obesity and severe OSA, Quentin Lisan, MD, of the Paris Cardiovascular Research Center and his colleagues conducted a multicenter, population-based cohort study. The researchers examined data for 392 participants in the Sleep Heart Health Study, in which adult men and women age 40 years or older were recruited from nine population-based studies between 1995 and 1998 and followed for a mean of 11.1 years. With each participant who had been prescribed PAP, the investigators matched as many as four participants who had not been prescribed PAP, on the basis of age, sex, and apnea-hypopnea index. Of this sample, 81 patients were prescribed PAP, and 311 were not.

All participants had a clinic visit and underwent overnight polysomnography at baseline. At 2-3 years, participants had a follow-up visit or phone call, during which they were asked whether their physicians had prescribed PAP. Participants were monitored for cardiovascular and all-cause mortality.

In all, 319 of the 392 participants were men; the population’s mean age was 63 years. Patients who had received a PAP prescription had a higher body mass index and more education, compared with patients who had not received a prescription. Mean follow-up duration was 11.6 years in the PAP-prescribed group and 10.9 years in the nonprescribed group.

A total of 96 deaths occurred during follow-up: 12 in the PAP-prescribed group and 84 in the nonprescribed PAP group. The crude incidence rate of mortality was 24.7 deaths per 1,000 person-years in the nonprescribed group and 12.8 deaths per 1,000 person-years in the PAP-prescribed group. The difference in survival between the prescribed and nonprescribed groups was evident in survival curves after 6-7 years of follow-up. After adjustments for prevalent cardiovascular disease, hypertension, diabetes, body mass index, education level, smoking status, and alcohol consumption, the hazard ratio of all-cause mortality for the prescribed group was 0.38, compared with the nonprescribed group.

Dr. Lisan and his colleagues identified 27 deaths of cardiovascular origin, one of which occurred in the prescribed group. After adjusting for prevalent cardiovascular disease, the hazard ratio of cardiovascular mortality for the prescribed group was 0.06, compared with the nonprescribed group.

One reason that the reduction in mortality associated with PAP was not found in previous randomized, controlled trials could be that their mean length of follow-up was not long enough, the researchers wrote. For example, the mean length of follow-up in the SAVE trial was 3.7 years, but the survival benefit was not apparent in the present analysis until 6-7 years after treatment initiation.

These results are exploratory and require confirmation in future research, Dr. Lisan and his colleagues wrote. No information on adherence to PAP was available, and the researchers could not account for initiation and interruption of PAP therapy. Nevertheless, “prescribing PAP in patients with OSA should be pursued and encouraged, given its potential major public health implication,” they concluded.

The Sleep Heart Health Study was supported by grants from the National Institutes of Health.

Author: Erik Greb

Source: https://www.mdedge.com/chestphysician/article/199393/sleep-medicine/pap-may-reduce-mortality-patients-obesity-and-severe

Cannabis, Cannabinoids, and Sleep: a Review of the Literature.


The current review aims to summarize the state of research on cannabis and sleep up to 2014 and to review in detail the literature on cannabis and specific sleep disorders from 2014 to the time of publication.


Preliminary research into cannabis and insomnia suggests that cannabidiol (CBD) may have therapeutic potential for the treatment of insomnia. Delta-9 tetrahydrocannabinol (THC) may decrease sleep latency but could impair sleep quality long-term. Novel studies investigating cannabinoids and obstructive sleep apnea suggest that synthetic cannabinoids such as nabilone and dronabinol may have short-term benefit for sleep apnea due to their modulatory effects on serotonin-mediated apneas. CBD may hold promise for REM sleep behavior disorder and excessive daytime sleepiness, while nabilone may reduce nightmares associated with PTSD and may improve sleep among patients with chronic pain. Research on cannabis and sleep is in its infancy and has yielded mixed results. Additional controlled and longitudinal research is critical to advance our understanding of research and clinical implications.

Author: Babson KA, Sottile J, Morabito D

Source: https://www.ncbi.nlm.nih.gov/pubmed/28349316

Obstructive sleep apnea: focus on myofunctional therapy


Orofacial myofunctional therapy (OMT) is a modality of treatment for children and adults with obstructive sleep apnea (OSA) to promote changes in the musculature of the upper airways. This review summarizes and discusses the effects of OMT on OSA, the therapeutic programs employed, and their possible mechanisms of action.


We conducted an online literature search using the databases MEDLINE/PubMed, EMBASE, and Web of Science. Search terms were “obstructive sleep apnea” in combination with “myofunctional therapy” OR “oropharyngeal exercises” OR “speech therapy”. We considered original articles in English and Portuguese containing a diagnosis of OSA based on polysomnography (PSG). The primary outcomes of interest for this review were objective measurement derived from PSG and subjective sleep symptoms. The secondary outcome was the evaluation of orofacial myofunctional status.


Eleven studies were included in this review. The studies reviewed reveal that several benefits of OMT were demonstrated in adults, which include significant decrease of apnea-hypopnea index (AHI), reduced arousal index, improvement in subjective symptoms of daytime sleepiness, sleep quality, and life quality. In children with residual apnea, OMT promoted a decrease of AHI, increase in oxygen saturation, and improvement of orofacial myofunctional status. Few of the studies reviewed reported the effects of OMT on the musculature.


The present review showed that OMT is effective for the treatment of adults in reducing the severity of OSA and snoring, and improving the quality of life. OMT is also successful for the treatment of children with residual apnea. In addition, OMT favors the adherence to continuous positive airway pressure. However, randomized and high-quality studies are still rare, and the effects of treatment should also be analyzed on a long-term basis, including measures showing if changes occurred in the musculature.

Source: https://www.ncbi.nlm.nih.gov/pubmed/30233265

Latest in Sleep Medicine Research

  1. Haghayegh, S, Khoshnevis, S, Smolensky, MH, Diller, KR, Castriotta, RJ. Before-bedtime passive body heating by warm shower or bath to improve sleep: A systematic review and meta-analysis. Sleep Med Rev. 2019;46 :124-135. doi: 10.1016/j.smrv.2019.04.008. PubMed PMID:31102877 .
  2. Grandou, C, Wallace, L, Fullagar, HHK, Duffield, R, Burley, S. The Effects of Sleep Loss on Military Physical Performance. Sports Med. 2019; :. doi: 10.1007/s40279-019-01123-8. PubMed PMID:31102110 .
  3. Corso, RM, Maitan, S, Cattano, D. Obstructive sleep apnoea: innocent bystander or associate in crime?. Br J Anaesth. 2019; :. doi: 10.1016/j.bja.2019.04.046. PubMed PMID:31101324 .
  4. Eichler, J, Schmidt, R, Hiemisch, A, Kiess, W, Hilbert, A. Gestational weight gain, physical activity, sleep problems, substance use, and food intake as proximal risk factors of stress and depressive symptoms during pregnancy. BMC Pregnancy Childbirth. 2019;19 (1):175. doi: 10.1186/s12884-019-2328-1. PubMed PMID:31101019 .
  5. Kant, D, Jha, SK. The formation of compensatory contextual fear memory in the absence of dorsal hippocampus does not change sleep architecture. Behav. Brain Res. 2019; :111944. doi: 10.1016/j.bbr.2019.111944. PubMed PMID:31100300 .
  6. Bazilio, DS, Bonagamba, LGH, Moraes, DJA, Machado, BH. Cardiovascular and respiratory profiles during the sleep-wake cycle of rats previously submitted to chronic intermittent hypoxia. Exp. Physiol. 2019; :. doi: 10.1113/EP087784. PubMed PMID:31099915 .
  7. Nieters, A, Blagitko-Dorfs, N, Peter, HH, Weber, S. Psychophysiological insomnia and respiratory tract infections: results of an infection-diary-based cohort study. Sleep. 2019; :. doi: 10.1093/sleep/zsz098. PubMed PMID:31099836 .
  8. Motohashi, T, Hirano, T, Okumura, K, Kashiyama, M, Ichikawa, D, Ueno, T et al.. Secure and Scalable mHealth Data Management Using Blockchain Combined With Client Hashchain: System Design and Validation. J. Med. Internet Res. 2019;21 (5):e13385. doi: 10.2196/13385. PubMed PMID:31099337 .
  9. Martins da Silva, R, Afonso, P, Fonseca, M, Teodoro, T. Comparing sleep quality in institutionalized and non-institutionalized elderly individuals. Aging Ment Health. 2019; :1-7. doi: 10.1080/13607863.2019.1619168. PubMed PMID:31099258 .
  10. Carvalho, CG, Yadollahi, A, Granton, J, Ryan, CM. Temporal shifts in fluid in pulmonary hypertension with and without sleep apnea. J Sleep Res. 2019; :e12863. doi: 10.1111/jsr.12863. PubMed PMID:31099115 .
  11. Kayabasi, S, Hizli, O, Yildirim, G. The association between obstructive sleep apnea and hearing loss: a cross-sectional analysis. Eur Arch Otorhinolaryngol. 2019; :. doi: 10.1007/s00405-019-05468-8. PubMed PMID:31098873 .
  12. den Daas, C, van den Berk, GEL, Kleene, M-T, de Munnik, ES, Lijmer, JG, Brinkman, K et al.. Health-related quality of life among adult HIV positive patients: assessing comprehensive themes and interrelated associations. Qual Life Res. 2019; :. doi: 10.1007/s11136-019-02203-y. PubMed PMID:31098796 .
  13. Iacovides, S, Goble, D, Paterson, B, Meiring, RM. Three consecutive weeks of nutritional ketosis has no effect on cognitive function, sleep, and mood compared with a high-carbohydrate, low-fat diet in healthy individuals: a randomized, crossover, controlled trial. Am. J. Clin. Nutr. 2019; :. doi: 10.1093/ajcn/nqz073. PubMed PMID:31098615 .
  14. Dizdar, D, Bozan, A, Dizdar, SK, Göde, S, Alpay, HC. Evaluation of nasal symptoms in septoplasty patients using SNOT-22. Acta Otorhinolaryngol Ital. 2019;39 (2):98-102. doi: 10.14639/0392-100X-2061. PubMed PMID:31097827 .
  15. Sapiña-Beltrán, E, Torres, G, Benítez, I, Santamaría-Martos, F, Durán-Cantolla, J, Egea, C et al.. Differential blood pressure response to CPAP treatment according to the circadian pattern in hypertensive patients with obstructive sleep apnea. Eur. Respir. J. 2019; :. doi: 10.1183/13993003.00098-2019. PubMed PMID:31097515 .
  16. Xie, J. Do obstructive sleep apnea and chronic obstructive pulmonary disease overlap coincidently or intrinsically?. Heart Lung. 2019; :. doi: 10.1016/j.hrtlng.2019.05.002. PubMed PMID:31097208 .
  17. Levy, I, Attias, S, Gavrieli, S, Oliven, R, Neerland, BE, Devlin, JW et al.. The study protocol for a randomized, controlled trial of acupuncture versus a sham procedure versus standard care alone for the treatment of delirium in acutely hospitalized older adults with a medical illness. Maturitas. 2019;124 :72-80. doi: 10.1016/j.maturitas.2019.03.001. PubMed PMID:31097183 .
  18. Aibar-Almazán, A, Hita-Contreras, F, Cruz-Díaz, D, de la Torre-Cruz, M, Jiménez-García, JD, Martínez-Amat, A et al.. Effects of Pilates training on sleep quality, anxiety, depression and fatigue in postmenopausal women: A randomized controlled trial. Maturitas. 2019;124 :62-67. doi: 10.1016/j.maturitas.2019.03.019. PubMed PMID:31097181 .
  19. Perger, E, Mattaliano, P, Lombardi, C. Menopause and Sleep Apnea. Maturitas. 2019;124 :35-38. doi: 10.1016/j.maturitas.2019.02.011. PubMed PMID:31097176 .
  20. Perger, E, Pengo, MF, Lombardi, C. Hypertension and atrial fibrillation in obstructive sleep apnea: Is it a menopause issue?. Maturitas. 2019;124 :32-34. doi: 10.1016/j.maturitas.2019.02.012. PubMed PMID:31097175 .
  21. Bos, MM, van Heemst, D, Donga, E, de Mutsert, R, Rosendaal, FR, Blauw, GJ et al.. The Association between Habitual Sleep Duration and Sleep Quality with Glycemic Traits: Assessment by Cross-Sectional and Mendelian Randomization Analyses. J Clin Med. 2019;8 (5):. doi: 10.3390/jcm8050682. PubMed PMID:31096629 .
  22. Xu, HW, Du, W, He, L, Kuang, X. Effectiveness and safety of warm needle acupuncture on insomnia in climacteric women: Protocol for a systematic review and meta-analysis. Medicine (Baltimore). 2019;98 (20):e15637. doi: 10.1097/MD.0000000000015637. PubMed PMID:31096480 .
  23. Rak, K, Völker, J, Taeger, J, Bahmer, A, Hagen, R, Albrecht, UV et al.. Medical Apps in Oto-Rhino-Laryngology. Laryngorhinootologie. 2019;98 (S 01):S253-S289. doi: 10.1055/a-0740-4866. PubMed PMID:31096301 .
  24. Evon, DM, Sarkar, S, Amador, J, Lok, AS, Sterling, RK, Stewart, PW et al.. Patient-reported symptoms during and after direct acting antiviral therapies for chronic hepatitis C: The PROP UP Study. J. Hepatol. 2019; :. doi: 10.1016/j.jhep.2019.04.016. PubMed PMID:31096006 .
  25. Jamilian, H, Amirani, E, Milajerdi, A, Kolahdooz, F, Mirzaei, H, Zaroudi, M et al.. The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2019; :109651. doi: 10.1016/j.pnpbp.2019.109651. PubMed PMID:31095994 .
Search PubMed

Search Terms: Insomnia, Narcolepsy, REM Sleep, Sleep Apnea, Sleep Quality